BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.

BD and Waters announced an agreement to create a new life science and diagnostics leader through a business combination.

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...

In this article, you’ll find some of the top content that was published on LCGC this week, including details on the recent merger between Waters Corporation and BD Biosciences.

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

Kirkland & Ellis advises Waters on $17.5B merger with Becton Dickinson, creating a diagnostics and life sciences leader.

Waters Corporation (WAT) stock downgraded at Wells Fargo based on execution risks related to its $17.5B M&A deal with a unit of Becton Dickinson (BDX). Read more here;.

Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...

Shares of Waters Corporation (NYSE:WAT) declined 2.2% following the announcement of a $17.5 billion Reverse Morris Trust deal ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.